Naming Convention, Interchangeability, and Patient Interest in Biosimilars

Although biosimilars may offer cost savings over their comparable biologics, use of biosimilars in the United States remains relatively low. This study investigates two barriers to uptake of biosimilars in the United States. First, the U.S. Food and Drug Administration requires that four-letter suff...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Diabetes Spectr
Hoofdauteurs: Socal, Mariana P., Garrett, Jace B., Tayler, William B., Bai, Ge, Anderson, Gerard F.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Diabetes Association 2020
Onderwerpen:
Feature Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7428664/
https://ncbi.nlm.nih.gov/pubmed/32848349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/ds19-0065
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items